DrugPatentWatch Database Preview
Helsinn Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for HELSINN, and when can generic versions of HELSINN drugs launch?
HELSINN has five approved drugs.
There are thirty-two US patents protecting HELSINN drugs.
There are two hundred and seventy-two patent family members on HELSINN drugs in sixty-eight countries and twenty-six supplementary protection certificates in fifteen countries.
Summary for Helsinn
| International Patents: | 272 |
| US Patents: | 32 |
| Tradenames: | 3 |
| Ingredients: | 4 |
| NDAs: | 5 |
| Patent Litigation for Helsinn: | See patent lawsuits for Helsinn |
| PTAB Cases with Helsinn as patent owner: | See PTAB cases with Helsinn as patent owner |
Drugs and US Patents for Helsinn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Helsinn | VALCHLOR | mechlorethamine hydrochloride | GEL;TOPICAL | 202317-001 | Aug 23, 2013 | RX | Yes | Yes | 8,501,818 | Start Trial | Y | Start Trial | |||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | AP | RX | Yes | Yes | 9,125,905*PED | Start Trial | Y | Start Trial | ||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | AP | RX | Yes | Yes | 9,457,020*PED | Start Trial | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Helsinn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | 5,202,333*PED | Start Trial |
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | 5,202,333 | Start Trial |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 5,202,333*PED | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Helsinn Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Panama | 8491101 | Start Trial |
| Montenegro | P5709 | Start Trial |
| Denmark | 1394150 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Helsinn Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1035115 | C300758 | Netherlands | Start Trial | PRODUCT NAME: NETUPITANT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH; REGISTRATION NO/DATE: EU/1/15/1001 20150527 |
| 1858864 | C20170027 00259 | Estonia | Start Trial | PRODUCT NAME: KLOORMETIIN;REG NO/DATE: EU/1/16/1171 07.03.2017 |
| 1035115 | 92745 | Luxembourg | Start Trial | PRODUCT NAME: NETUPITANT/PALONOSETRON ET LEURS DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (AKYNZEO); FIRST REGISTRATION: 20150527 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
